- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
已发现中线买入信号。
- 长期趋势：
已有186家主力机构披露2025-12-31报告期持股数据，持仓量总计2.02亿股，占流通A股30.46%
- 波段诊断：
-
技术面诊股
诊断结果：4.8技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为18.30元。空头行情中，目前正处于反弹阶段，投资者可适当关注。已发现中线买入信号。
平均成本
近期的平均成本为18.30元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"18.30","date":1781424958,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.06.15","stock":"0.66","trade":null,"ind":"1.61"},{"date":"2026.06.12","stock":"0.61","trade":null,"ind":"1.12"},{"date":"2026.06.11","stock":"-3.27","trade":null,"ind":"-0.16"},{"date":"2026.06.10","stock":"-0.27","trade":null,"ind":"-0.42"},{"date":"2026.06.09","stock":"-1.89","trade":null,"ind":"1.28"},{"date":"2026.06.08","stock":"-3.20","trade":null,"ind":"-1.70"},{"date":"2026.06.05","stock":"2.60","trade":null,"ind":"-0.74"},{"date":"2026.06.04","stock":"0.73","trade":null,"ind":"-0.64"},{"date":"2026.06.03","stock":"-0.78","trade":null,"ind":"0.22"},{"date":"2026.06.02","stock":"0.26","trade":null,"ind":"0.43"},{"date":"2026.06.01","stock":"-0.10","trade":null,"ind":"-0.27"},{"date":"2026.05.29","stock":"5.91","trade":null,"ind":"-0.73"},{"date":"2026.05.28","stock":"-3.57","trade":null,"ind":"0.12"},{"date":"2026.05.27","stock":"-0.74","trade":null,"ind":"-1.25"},{"date":"2026.05.26","stock":"-2.67","trade":null,"ind":"-0.17"},{"date":"2026.05.25","stock":"4.63","trade":null,"ind":"0.96"},{"date":"2026.05.22","stock":"5.09","trade":null,"ind":"0.87"},{"date":"2026.05.21","stock":"1.84","trade":null,"ind":"-2.04"},{"date":"2026.05.20","stock":"-0.52","trade":null,"ind":"-0.18"},{"date":"2026.05.19","stock":"0.69","trade":null,"ind":"0.92"},{"date":"2026.05.18","stock":"-0.96","trade":null,"ind":"-0.09"}]
山东药玻,上证指数,医疗器械指数
压力支撑
该股压力位为18.30元，支撑位为18.07元。
[{"text":"\u538b\u529b\u4f4d","value":"18.30","date":1781452800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"18.07","date":1781452800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。已发现中线买入信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.7资金面打败了1%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月15日 20:31
| 机构今日流向(万元) | -703.34 | 机构5日流向(万元) | -2040.87 |
| 机构10日流向(万元) | -5172.42 | 机构20日流向(万元) | -11240.41 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少4571.07万股，其中基金净减仓54家，主力净减仓90家，请投资者中长期谨慎为宜。
截止2025-12-31，共186家主力机构（基金183家，券商1家，一般法人2家），持仓量总计20214.2万股，占流通A股30.46%
其中，基金持仓与2025-06-30相比：
增仓：28家 ，增持 539.54万股
减仓：82家 ，减持 593.57万股
新出现在主力名单中：62家 ，持有1778.81万股
从主力名单中消失：152家 ，原持有6187.78万股
其中，基金持仓与2025-06-30相比：
增仓：28家 ，增持 539.54万股
减仓：82家 ，减持 593.57万股
新出现在主力名单中：62家 ，持有1778.81万股
从主力名单中消失：152家 ，原持有6187.78万股
消息面诊股
诊断结果：6.1消息面打败了93%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 山东药玻：6月12日获融资买入1120.52万元
2026-06-13 - 山东药玻：6月11日获融资买入2513.41万元
2026-06-12 - 山东药玻：6月10日获融资买入2441.59万元
2026-06-11 - 山东药玻：6月9日获融资买入2820.74万元
2026-06-10 - 山东药玻：6月8日获融资买入3137.60万元
2026-06-09 - 一块玻璃基板，如何撬动千亿半导体新赛道？
2026-06-08 - 锁价定增改市价定增，卖买上市公司都要趁早，搭上了车
2026-06-09 - 玻璃基板深度报告汇报
2026-06-07 - 山东药玻：6月5日获融资买入6786.97万元
2026-06-06 - 山东药玻：6月4日获融资买入2493.78万元
2026-06-05
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2026-04-11 |
| 一般消息 | 募资投向 | 2026-04-10 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-07 |
| 利好 | 分红转增 | 10派1.8元(含税) | 2026-03-07 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-20 |
| 利好 | 股票增发 | 董事会通过 | 2026-01-14 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-01-14 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-14 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-31 |
| 一般消息 | 高管变动 | 因年龄原因 | 2025-12-23 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-12 |
| 利好 | 分红转增 | 10派2.8元(含税) | 2025-08-26 |
| 一般消息 | 高管变动 | 委员会更名 | 2025-08-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：3.5行业面打败了55%的股票
医疗器械行业最新资金流向
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
[{"date":"2026.06.15","price":"1.61","value":null},{"date":"2026.06.12","price":"1.12","value":null},{"date":"2026.06.11","price":"-0.16","value":null},{"date":"2026.06.10","price":"-0.42","value":null},{"date":"2026.06.09","price":"1.28","value":null},{"date":"2026.06.08","price":"-1.70","value":null},{"date":"2026.06.05","price":"-0.74","value":null},{"date":"2026.06.04","price":"-0.64","value":null},{"date":"2026.06.03","price":"0.22","value":null},{"date":"2026.06.02","price":"0.43","value":null},{"date":"2026.06.01","price":"-0.27","value":null},{"date":"2026.05.29","price":"-0.73","value":null},{"date":"2026.05.28","price":"0.12","value":null},{"date":"2026.05.27","price":"-1.25","value":null},{"date":"2026.05.26","price":"-0.17","value":null},{"date":"2026.05.25","price":"0.96","value":null},{"date":"2026.05.22","price":"0.87","value":null},{"date":"2026.05.21","price":"-2.04","value":null},{"date":"2026.05.20","price":"-0.18","value":null},{"date":"2026.05.19","price":"0.92","value":null},{"date":"2026.05.18","price":"-0.09","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 力诺药包 | 49.67% | 12.24% | 6.5分 |
| 2 | 正川股份 | 19.34% | 10.00% | 6.3分 |
| 3 | 奕瑞科技 | 12.91% | -1.14% | 5.6分 |
| 4 | 华兰股份 | 11.91% | 1.30% | 5.0分 |
| 5 | 大博医疗 | 6.04% | 5.80% | 6.5分 |
| 6 | 万孚生物 | 5.52% | 7.01% | 4.2分 |
| 8 | 联影医疗 | 3.25% | -1.26% | 5.6分 |
| 10 | 安图生物 | -0.31% | 6.26% | 5.1分 |
| 12 | 英诺特 | -1.10% | 9.85% | 5.6分 |
| 14 | 赛诺医疗 | -1.58% | 2.67% | 4.4分 |
| 16 | 爱迪特 | -2.64% | 17.05% | 5.4分 |
| 18 | 理邦仪器 | -3.54% | 8.43% | 5.7分 |
| 20 | 麦克奥迪 | -3.99% | 1.08% | 5.9分 |
| 22 | 利德曼 | -4.16% | 10.87% | 4.3分 |
| 24 | 鱼跃医疗 | -4.84% | 3.36% | 5.0分 |
| 26 | - | -5.04% | -2.22% | 分 |
| 28 | 迈瑞医疗 | -5.34% | 2.63% | 4.9分 |
| 30 | 天智航 | -5.63% | 7.99% | 5.5分 |
| 32 | 华大智造 | -5.83% | 4.75% | 5.4分 |
| 34 | 佰仁医疗 | -6.07% | 11.08% | 5.4分 |
| 36 | 心脉医疗 | -7.01% | -6.44% | 4.7分 |
| 38 | 健信超导 | -8.14% | 2.66% | 5.8分 |
| 40 | 迈普医学 | -8.24% | 8.74% | 4.6分 |
| 42 | 奥泰生物 | -8.64% | -2.41% | 3.8分 |
| 44 | 博拓生物 | -9.02% | 5.50% | 4.1分 |
| 46 | 新产业 | -9.17% | -2.39% | 4.8分 |
| 48 | *ST明德 | -9.29% | -3.18% | 3.5分 |
| 50 | 惠泰医疗 | -9.42% | 3.22% | 5.9分 |
| 52 | 山外山 | -9.53% | 5.48% | 6.1分 |
| 54 | 乐普医疗 | -9.89% | 1.88% | 4.8分 |
| 56 | 健尔康 | -10.21% | 0.93% | 4.6分 |
| 58 | 维力医疗 | -10.37% | 2.62% | 4.7分 |
| 60 | 英科医疗 | -10.60% | -1.29% | 4.6分 |
| 62 | 康众医疗 | -11.06% | -1.41% | 5.3分 |
| 64 | - | -11.32% | -2.72% | 分 |
| 66 | 国发股份 | -11.36% | -2.66% | 4.4分 |
| 68 | 康泰医学 | -11.73% | -0.37% | 4.1分 |
| 70 | 宝莱特 | -12.09% | 6.64% | 4.5分 |
| 72 | 正海生物 | -12.16% | 0.34% | 4.4分 |
| 74 | 超研股份 | -12.66% | 2.79% | 5.1分 |
| 76 | 伟思医疗 | -13.02% | 7.09% | 5.4分 |
| 78 | 昊海生科 | -13.10% | -1.19% | 4.2分 |
| 80 | 欧普康视 | -13.37% | 1.53% | 4.5分 |
| 82 | 硕世生物 | -13.41% | 9.93% | 4.1分 |
| 84 | - | -13.89% | -4.37% | 分 |
| 86 | 科华生物 | -14.04% | -1.17% | 4.4分 |
| 88 | ST迪瑞 | -14.07% | -6.04% | 4.1分 |
| 90 | 乐心医疗 | -14.30% | 0.34% | 3.9分 |
| 92 | 艾德生物 | -14.54% | -5.23% | 4.0分 |
| 94 | - | -14.66% | -8.39% | 分 |
| 96 | 之江生物 | -15.19% | -6.55% | 3.9分 |
| 98 | 迈克生物 | -15.69% | -1.59% | 3.8分 |
| 100 | 爱博医疗 | -16.05% | -0.70% | 4.2分 |
| 102 | *ST海利 | -16.26% | -6.36% | 3.2分 |
| 104 | 威高骨科 | -16.52% | -2.00% | 5.0分 |
| 106 | 采纳股份 | -16.78% | -5.64% | 4.7分 |
| 108 | 天益医疗 | -16.83% | 4.87% | 5.4分 |
| 110 | - | -16.92% | -7.49% | 分 |
| 112 | 拱东医疗 | -17.14% | 0.18% | 5.0分 |
| 114 | - | -17.64% | -7.03% | 分 |
| 116 | 港通医疗 | -17.90% | -1.56% | 4.1分 |
| 118 | 达安基因 | -18.37% | -6.87% | 4.4分 |
| 120 | 澳华内镜 | -18.52% | -1.25% | 4.8分 |
| 122 | 奥美医疗 | -18.88% | 1.00% | 4.9分 |
| 124 | 济民健康 | -19.18% | -5.49% | 3.7分 |
| 126 | 阳普医疗 | -20.89% | -1.99% | 4.4分 |
| 128 | 亚辉龙 | -21.36% | 0.53% | 4.3分 |
| 130 | 爱威科技 | -22.19% | -3.31% | 4.0分 |
| 132 | 爱朋医疗 | -22.51% | -0.24% | 4.3分 |
| 134 | 福瑞医科 | -23.54% | 6.75% | 4.9分 |
| 136 | 三友医疗 | -24.82% | -1.83% | 4.0分 |
| 138 | 浩欧博 | -28.53% | -0.83% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 31/243 ， 106/243。
[{"date":"2026-03-31","value":"2.41","vol":"1.15"},{"date":"2025-12-31","value":"8.46","vol":"2.66"},{"date":"2025-09-30","value":"6.71","vol":"2.97"},{"date":"2025-06-30","value":"4.59","vol":"2.34"},{"date":"2025-03-31","value":"2.75","vol":"1.15"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.41 | 8.46 | 6.71 | 4.59 | 2.75 |
| 行业(%) | 1.15 | 2.66 | 2.97 | 2.34 | 1.15 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"32.56","vol":"52.18"},{"date":"2025-12-31","value":"33.31","vol":"51.61"},{"date":"2025-09-30","value":"33.56","vol":"51.74"},{"date":"2025-06-30","value":"33.37","vol":"52.05"},{"date":"2025-03-31","value":"32.04","vol":"51.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
32.56 | 33.31 | 33.56 | 33.37 | 32.04 |
| 行业(%) | 52.18 | 51.61 | 51.74 | 52.05 | 51.74 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 59/243 ， 72/243。
[{"date":"2026-03-31","value":"4.09","vol":"5.49"},{"date":"2025-12-31","value":"-8.78","vol":"1.44"},{"date":"2025-09-30","value":"-8.51","vol":"0.26"},{"date":"2025-06-30","value":"-9.70","vol":"-1.09"},{"date":"2025-03-31","value":"-4.57","vol":"-0.12"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.09 | -8.78 | -8.51 | -9.70 | -4.57 |
| 行业(%) | 5.49 | 1.44 | 0.26 | -1.09 | -0.12 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-10.03","vol":"-16.14"},{"date":"2025-12-31","value":"-26.87","vol":"-25.45"},{"date":"2025-09-30","value":"-24.70","vol":"-15.37"},{"date":"2025-06-30","value":"-21.89","vol":"-18.14"},{"date":"2025-03-31","value":"1.29","vol":"-2.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-10.03 | -26.87 | -24.70 | -21.89 | 1.29 |
| 行业(%) | -16.14 | -25.45 | -15.37 | -18.14 | -2.57 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/243 ， 60/243。
[{"date":"2026-03-31","value":"0.12","vol":"0.08"},{"date":"2025-12-31","value":"0.44","vol":"0.35"},{"date":"2025-09-30","value":"0.33","vol":"0.25"},{"date":"2025-06-30","value":"0.22","vol":"0.17"},{"date":"2025-03-31","value":"0.12","vol":"0.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.44 | 0.33 | 0.22 | 0.12 |
| 行业(次) | 0.08 | 0.35 | 0.25 | 0.17 | 0.08 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.49","vol":"0.55"},{"date":"2025-12-31","value":"2.01","vol":"2.33"},{"date":"2025-09-30","value":"1.54","vol":"1.66"},{"date":"2025-06-30","value":"1.06","vol":"1.12"},{"date":"2025-03-31","value":"0.59","vol":"0.54"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.49 | 2.01 | 1.54 | 1.06 | 0.59 |
| 行业(次) | 0.55 | 2.33 | 1.66 | 1.12 | 0.54 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"17.47","vol":"0.09"},{"date":"2025-12-31","value":"5.88","vol":"32.02"},{"date":"2025-09-30","value":"19.20","vol":"14.74"},{"date":"2025-06-30","value":"19.36","vol":"15.54"},{"date":"2025-03-31","value":"7.73","vol":"4.16"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 17.47 | 5.88 | 19.20 | 19.36 | 7.73 |
| 行业 | 0.09 | 32.02 | 14.74 | 15.54 | 4.16 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.59","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.19","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.59 | - | 1.19 | - |
| 行业 | 0.00 | 1.59 | 0.01 | 1.57 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 61/243 ， 57/243。
[{"date":"2026-03-31","value":"3.79","vol":"6.20"},{"date":"2025-12-31","value":"3.75","vol":"5.29"},{"date":"2025-09-30","value":"3.61","vol":"5.66"},{"date":"2025-06-30","value":"3.51","vol":"5.47"},{"date":"2025-03-31","value":"3.34","vol":"5.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.79 | 3.75 | 3.61 | 3.51 | 3.34 |
| 行业 | 6.20 | 5.29 | 5.66 | 5.47 | 5.80 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.69","vol":"5.06"},{"date":"2025-12-31","value":"2.64","vol":"4.14"},{"date":"2025-09-30","value":"2.52","vol":"4.51"},{"date":"2025-06-30","value":"2.53","vol":"4.35"},{"date":"2025-03-31","value":"2.47","vol":"4.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.69 | 2.64 | 2.52 | 2.53 | 2.47 |
| 行业 | 5.06 | 4.14 | 4.51 | 4.35 | 4.69 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 66/243 ， 66/243。
[{"date":"2026-03-31","value":"17.37","vol":"21.96"},{"date":"2025-12-31","value":"17.42","vol":"22.90"},{"date":"2025-09-30","value":"17.54","vol":"22.07"},{"date":"2025-06-30","value":"18.15","vol":"22.01"},{"date":"2025-03-31","value":"19.10","vol":"21.02"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.37 | 17.42 | 17.54 | 18.15 | 19.10 |
| 行业(%) | 21.96 | 22.90 | 22.07 | 22.01 | 21.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.21","vol":"0.39"},{"date":"2025-12-31","value":"0.21","vol":"0.40"},{"date":"2025-09-30","value":"0.21","vol":"0.71"},{"date":"2025-06-30","value":"0.22","vol":"0.58"},{"date":"2025-03-31","value":"0.24","vol":"0.56"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.21 | 0.21 | 0.21 | 0.22 | 0.24 |
| 行业(%) | 0.39 | 0.40 | 0.71 | 0.58 | 0.56 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国联民生 | 2026-05-03 | 买入 | |
| 长江证券 | 2026-04-30 | 买入 | 买入 |
| 东北证券 | 2026-04-02 | 增持 | |
| 国海证券 | 2026-03-21 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"6.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"7.76","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"9.43","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.90","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"7.97","blueLineValue":"1.20","type":"YC"}]